Evidence map›Paper›PMID 36641472›Full record

ArticleWorld journal of surgical oncology2023

The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study.

Mike van Dooren, Elise A J de Savornin Lohman, Eva Brekelmans, Pauline A J Vissers, Joris I Erdmann, Andries E Braat, Jeroen Hagendoorn, Freek Daams, Ronald M van Dam, Marieke T de Boer and 3 more

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. New trends in diagnosis and management of gallbladder carcinoma.World journal of gastrointestinal oncology · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Mike van DoorenDepartment of Surgery, Radboud university medical center, P.O. Box 9101, Internal Code 618, 6500 HB, Nijmegen, the Netherlands. mike.vandooren@radboudumc.nl.
Elise A J de Savornin LohmanDepartment of Surgery, Radboud university medical center, P.O. Box 9101, Internal Code 618, 6500 HB, Nijmegen, the Netherlands.
Eva BrekelmansDepartment of Surgery, Radboud university medical center, P.O. Box 9101, Internal Code 618, 6500 HB, Nijmegen, the Netherlands.
Pauline A J VissersDepartment of Research, Netherlands Comprehensive Cancer Organization (IKNL), P.O. Box 19079, 3501 DB, Utrecht, the Netherlands.
Joris I ErdmannDepartment of Surgery, Amsterdam University Medical Centers, P.O. Box 22660, 1100 DD, Amsterdam, the Netherlands.
Andries E BraatDepartment of Surgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, the Netherlands.
Jeroen HagendoornDepartment of Surgery, UMC Utrecht Cancer Center, P.O. Box 85500, 3508 GA, Utrecht, the Netherlands.
Freek DaamsDepartment of Surgery, Amsterdam University Medical Centers, P.O. Box 22660, 1100 DD, Amsterdam, the Netherlands.
Ronald M van DamDepartment of Surgery, Maastricht University Medical Center +, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.
Marieke T de BoerDepartment of Hepatobiliary and Transplant Surgery, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands.
Peter B van den BoezemDepartment of Surgery, Radboud university medical center, P.O. Box 9101, Internal Code 618, 6500 HB, Nijmegen, the Netherlands.
Bas Groot KoerkampDepartment of Surgery, Erasmus MC, P.O. Box 2060, 3000 CB, Rotterdam, the Netherlands.
Philip R de ReuverDepartment of Surgery, Radboud university medical center, P.O. Box 9101, Internal Code 618, 6500 HB, Nijmegen, the Netherlands. philip.dereuver@radboudumc.nl.
Radboud University Nijmegen · NLAmsterdam University Medical Centers · NLErasmus University Rotterdam · NLLeiden University Medical Center · NLMaastricht University · NLNetherlands Comprehensive Cancer Organisation · NLSt. Antonius Ziekenhuis · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisseminated disease (DD) is often found at (re-)exploration in gallbladder cancer (GBC) patients. We aimed to assess the yield of staging laparoscopy (SL) and identify predictors for DD.

methodsThis retrospective study included patients from all Dutch academic centres with primary GBC (pGBC) and incidentally diagnosed GBC (iGBC) planned for (re-)resection. The yield of SL was determined. In iGBC, predictive factors for DD were assessed.

resultsIn total, 290 patients were included. Of 183 included pGBC patients, 143 underwent laparotomy without SL, and 42 (29%) showed DD perioperatively. SL, conducted in 40 patients, identified DD in eight. DD was found in nine of 32 patients who underwent laparotomy after SL. Of 107 included iGBC patients, 100 underwent laparotomy without SL, and 19 showed DD perioperatively. SL, conducted in seven patients, identified DD in one. Cholecystitis (OR = 4.25; 95% CI 1.51-11.91) and primary R1/R2 resection (OR = 3.94; 95% CI 1.39-11.19) were independent predictive factors for DD.

conclusionsIn pGBC patients, SL may identify DD in up to 20% of patients and should be part of standard management. In iGBC patients, SL is indicated after primary resection for cholecystitis and after initial R1/R2 resection due to the association of these factors with DD.

Indexed as

Carcinoma in SituCholecystitisGallbladder NeoplasmsLaparoscopyCohort StudiesHumansNeoplasm StagingRetrospective StudiesGallbladder carcinomaGallbladder neoplasmsStaging laparoscopy

Identifiers

PMID36641472
PMCPMC9840315
OpenAlexW4316034943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.